Last reviewed · How we verify
Placebo Jelly — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo Jelly (Placebo Jelly) — University of South Florida. Placebo Jelly is an inert formulation used as a control comparator in clinical trials to establish the efficacy of active pharmaceutical agents through blinded comparison.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo Jelly TARGET | Placebo Jelly | University of South Florida | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo Jelly CI watch — RSS
- Placebo Jelly CI watch — Atom
- Placebo Jelly CI watch — JSON
- Placebo Jelly alone — RSS
Cite this brief
Drug Landscape (2026). Placebo Jelly — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-jelly. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab